Category - Pharma Industry News
Zolgensma shows promise in presymptomatic SMA patients
EC approves Sanofi’s Aubagio for paediatric MS patients
Court rules on AZ and EU’s COVID-19 vaccine dispute
Biogen doses first patient in phase 3 systemic lupus erythematosus study
US announces $3bn funding boost for antiviral COVID-19 treatments
BMS and Eisai to collaborate in deal worth up to $3.1bn
Novartis’ Cosentyx wins NICE backing for non-radiographic axial spondyloarthritis
Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia